What type of study is this?

This is a In Vitro Study study.

Docosahexaenoic acid (DHA) alleviates hepatic lipid deposition in dairy cows during the transition period: an integrated in vitro and in vivo study

View Full Paper

Ask AI

Bookmark

Authors

In vivo trials show DHA supplementation reduces hepatic lipid deposition in dairy cows, indicating improved liver function and metabolic health.

DHA supplementation significantly lowers hepatic lipid levels, enhancing liver function and metabolism in dairy cows.
In vivo results showed a decrease in total bilirubin and alanine aminotransferase due to DHA treatment.
This observational analysis included in vitro models to understand DHA's role in lipid metabolism activation.
Overall findings support DHA as a beneficial nutritional approach for managing fatty liver syndrome in dairy cows.

Liu et al. (2025) studied this question.

View Full Paper

Ask AI

Bookmark

In vivo trials show DHA supplementation reduces hepatic lipid deposition in dairy cows, indicating improved liver function and metabolic health.